
Nanotechnology Drug Delivery Market
Nanotechnology Drug Delivery Market Global Industry Assessment & Forecast
Segments Covered
By Technology Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others
By Application Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others
Snapshot
![]() |
2021 - 2028 |
![]() |
2016 - 2020 |
![]() |
1232 Million |
![]() |
6355 Million |
![]() |
4.6 |
![]() |
North America |
Customization Offered
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst
Key insights
The global Nanotechnology Drug Delivery market was valued at USD 1232 Million in 2020 and is projected to reach USD 6355 Million by 2028, growing at a CAGR of 4.6% from 2021 to 2028.

Years | Parameters |
---|---|
Historical Data (Actual Data) | 2016-2020 |
Base Year Data | 2020 |
Current Year Date | 2021 |
Projected year data | 2021-2026 |
Annual Market Size (2028) | 6355 Million |
Annual Market Size (2021) | |
CAGR (2021 - 2028) | 4.6% |
Definition And Overview
The most publicized use of nanotechnology in drug delivery under development is the use of nanoparticles to deliver drugs to cancer cells. Particles are engineered so that they are attracted to diseased cells, which allows direct treatment of those cells. This technique reduces damage to healthy cells in the body.
The report covers in-depth study on the global Nanotechnology Drug Delivery market, which comprises market trends such as drivers, restraints, and opportunities, regional trends, segmental analysis, and competitive landscape among others. This study comprises the market estimations and forecast in terms of revenue for each segment at the global/regional/country level along with a detailed analysis of growth prospects, challenges, and opportunities. The report includes a separate chapter covering detailed Nanotechnology Drug Delivery market overview that includes Porter’s Five Forces Analysis, PESTLE Analysis, Player Positioning Analysis, SWOT Analysis, and Value Chain Analysis among others.
COVID-19 Impact Analysis
The wise spread
COVID-19 outbreak has impacted several industries including Nanotechnology Drug Delivery. The
governments across the globe compel to employ stringent restriction such as
lockdown, international border seals, and
implementing strict social distancing measures. This forces serval
industries to opt for work from home which in turn disrupted the business
processes. However, after mid 2021 the world is witnessing reopening of trading
activities, business operations which is expected to stimulate the economic
growth during upcoming years. The impact
of COVID-19 on the market demand is considered while estimating the current and
forecast market size and growth trends for all the regions and countries. The
report provides a completely separate chapter for COVID-19 Impact Analysis.
This chapter includes: o
Impact Assessment of COVID-19 Pandemic o
Pre & Post COVID-19 Market Size o
Qualitative analysis on the short term
& long-term impact of COVID-19 on the market
o The
analysis provides foremost strategies adopted by competitors to minimize the
impact of the pandemic on their business activities and scope for future
developments.
Industry Analysis
The report explains various driving factors, restraints/challenges, and opportunities in detail. These assessments aid the industry stakeholders to analyze the Nanotechnology Drug Delivery market on the basis of different parameters, such as economies of scale, the share of various distribution channels, various factors affecting consumer behavior such as brand loyalty, price, and product availability among others, capital investments, regulatory landscape, production rights and patents, promotional strategies, and other customer preferences.
It is a growing area and is witnessing rising acceptance in applications in health care. It is broadly used in applications like anti-infective, neurology, cardiovascular disorders, among others.
One active and important application area is to commute drugs to the location of therapeutic interference within the body. The market is observing swift growth owing to rise in R&D activities to develop novel nano-medicine in nanotechnology.
Strict regulations scenario and huge improvement cost of medicines are expected to hamper Nanotechnology Drug Delivery growth.
Global Nanotechnology Drug Delivery Market Report Scope
Parameter | Details |
---|---|
Market Size Provided for Years | 2016-2028 |
Base Year | 2020 |
Historic Years | 2016-2020 |
Forecast Years | 2021-2028 |
Market Size Provided In Terms Of | Revenue & Volume |
Segments Covered | Technology, Application |
Regions Covered | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Countries Covered | The U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, South East Asia, Brazil, Argentina, GCC Countries, and South Africa, among others |
Companies Covered | Merck & Co., Bayer AG, Amgen, Pfizer, Novartis International AG, AbbVie, Roche, Johnson & Johnson, Celgene Corporation. |
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis |
Market Segmentation
The report
delivers an acute breakdown of the market based on various segments such as Technology,
Application, and region. The report will cover market
estimations and forecast for each segment by region for the years 2016–2028. Several
growth factors and opportunities impacting various segments have been
incorporated in the report. On
the basis of Technology, the market is divided into Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, Others. Nanoparticles
held the largest share in 2020 and is projected to witness substantial growth
during the forecast period.
Based
on Application, the market is divided into Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, Others. Neurology
attributed to the highest market share and is expected to grow at a significant
CAGR from 2021 to 2028.
Global Nanotechnology Drug Delivery Market: Technology Segment Analysis
-
- Nanocrystals
- Nanoparticles
- Liposomes
- Micelles
- Nanotubes
- Others
Global Nanotechnology Drug Delivery Market: Application Segment Analysis
-
- Neurology
- Oncology
- Cardiovascular/Physiology
- Anti-inflammatory/Immunology
- Anti-infective
- Others
Global Nanotechnology Drug Delivery Market: Regional Analysis
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
The global Nanotechnology Drug Delivery market report provides an exhaustive competitive landscape to give a comprehensive synopsis of the global market. Major players in the Nanotechnology Drug Delivery market are Merck & Co., Bayer AG, Amgen, Pfizer, Novartis International AG, AbbVie, Roche, Johnson & Johnson, Celgene Corporation.. This section of the report will provide you extensive information on all key players based on business overview, product portfolio, marketing strategies, recent developments, financial performance, and geographical presence among others. Moreover, the report also includes extensive information on key strategies such as new product development/launch, merger & acquisitions, partnerships, collaborations & joint ventures, research & development, and regional expansion.
Global Nanotechnology Drug Delivery Market : Regional Analysis
Based on the geography, the global Nanotechnology Drug Delivery market is segmented into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa. The regional analysis covers market estimations and forecast for each segment for each region for the years 2016–2028. The concentration of raw material suppliers as well as market players in one specific region impacts the global market scenario and the report covers exclusive information on the same. Also, the report analyzes the intensity of competition in each region and its influence on the growth of the global Nanotechnology Drug Delivery market.
Market Size, 2021 (USD Billion)
FAQ
Frequently Asked Question
What is the global demand for Nanotechnology Drug Delivery in terms of revenue?
-
The global Nanotechnology Drug Delivery valued at 1232 Million in 2020 and is expected to reach 6355 Million in 2028 growing at a CAGR of 4.6%.
Which are the prominent players in the market?
-
The prominent players in the market are Merck & Co., Bayer AG, Amgen, Pfizer, Novartis International AG, AbbVie, Roche, Johnson & Johnson, Celgene Corporation..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 4.6% between 2021 and 2028.
What are the driving factors fueling the growth of the market?
-
The driving factors of the Nanotechnology Drug Delivery include
- It is a growing area and is witnessing rising acceptance in applications in health care. It is broadly used in applications like anti-infective, neurology, cardiovascular disorders, among others.
- One active and important application area is to commute drugs to the location of therapeutic interference within the body. The market is observing swift growth owing to rise in R&D activities to develop novel nano-medicine in nanotechnology.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Nanotechnology Drug Delivery in 2020.